Wolfe Research Downgrades Oak Street Health (OSH)
Nasdaq On March 21, 2023, Wolfe Research downgraded their outlook for Oak Street Health (NYSE:OSH) from Outperform to Peer Perform.
Analyst Price Forecast Suggests 4.08% Upside
As of March 21, 2023, the average one-year price target for Oak Street Health is $37.16. The forecasts range from a low of $21.21 to a high of $67.20. The average price target represents an increase of 4.08% from its latest reported closing price of $35.70.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Oak Street Health is $3,071MM, an increase of 42.12%. The projected annual non-GAAP EPS is -$1.70.
What are Large Shareholders Doing?
General Atlantic holds 61,384K shares representing 25.16% ownership of the company. No change in the last quarter.
Newlight Partners holds 32,550K shares representing 13.34% ownership of the company. In it's prior filing, the firm reported owning 32,671K shares, representing a decrease of 0.37%. The firm decreased its portfolio allocation in OSH by 99.90% over the last quarter.
